세계 이식형 주입 펌프 시장 : 시장 규모의 분석(제품 유형별, 용도별, 최종 사용자별, 지역별)과 예측(2022 - 2032년)

The Global Implantable Infusion Pumps Market, valued at approximately USD 19.23 billion in 2023, is anticipated to grow at a steady CAGR of 5.30% over the forecast period from 2024 to 2032. Implantable infusion pumps represent a significant leap forward in targeted drug delivery technology, revolutionizing the management of chronic diseases and improving patient outcomes. These medical devices are surgically implanted to provide controlled, continuous drug delivery directly to specific areas of the body, offering superior efficacy while minimizing systemic side effects. With applications spanning cancer treatment, pain management, diabetes control, and pediatric care, implantable infusion pumps are becoming indispensable in modern medicine. The market's growth trajectory is underpinned by the escalating prevalence of chronic diseases, an aging global population, and continuous advancements in medical technologies.

The surge in chronic diseases, including cancer, diabetes, and neurological disorders, is a major driver fueling the demand for implantable infusion pumps. These devices offer unparalleled precision in drug administration, reducing the burden of frequent hospital visits and enhancing patient compliance. Additionally, the integration of advanced technologies, such as wireless monitoring and programmable features, has expanded the versatility of these pumps, enabling tailored therapeutic regimens. While these developments hold immense promise, the high costs of implantable infusion systems and the need for skilled professionals to manage their operation may present challenges to widespread adoption. Nonetheless, government initiatives, healthcare infrastructure enhancements, and increased R&D funding are expected to mitigate these obstacles, fostering sustained market growth.

The geographical landscape of the Global Implantable Infusion Pumps Market reveals diverse growth dynamics across regions. North America leads the market, driven by advanced healthcare infrastructure, high healthcare spending, and the presence of leading market players. Europe follows suit, benefiting from robust government support for healthcare innovation and a strong focus on chronic disease management. Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, propelled by increasing healthcare awareness, rising disposable incomes, and significant investments in healthcare infrastructure. Countries such as China, India, and Japan are at the forefront of this growth, leveraging their large patient populations and burgeoning medical device industries.

Advancements in the implantable infusion pumps market continue to reshape the therapeutic landscape. Innovations such as miniaturized pumps, AI-assisted programming, and remote monitoring capabilities are setting new benchmarks in patient care. The growing emphasis on personalized medicine and targeted therapies is further accelerating the adoption of these devices, making them a cornerstone in chronic disease management strategies. Collaborative efforts among medical device manufacturers, healthcare providers, and regulatory bodies are expected to drive innovation and accessibility, ensuring the long-term success of this vital market.

Major market players included in this report are:

• Medtronic PLC
• Smiths Medical
• Flowonix Medical Inc.
• BD (Becton, Dickinson and Company)
• Baxter International Inc.
• Roche Diagnostics
• Fresenius Kabi AG
• Terumo Corporation
• ICU Medical Inc.
• Insulet Corporation
• Johnson & Johnson
• Moog Inc.
• Tandem Diabetes Care Inc.
• Abbott Laboratories
• Boston Scientific Corporation

The detailed segments and sub-segments of the market are explained below:

By Product Type:

• Piston Type Infusion Pumps
• Creeping Type Infusion Pumps
• Enteral Pump
• Elastomeric Pump
• Insulin Pump
• Syringe Pump

By Application:

• Cancer Treatment
• Spasticity
• Analgesia
• Diabetes Mellitus
• Gastroenterology
• Hematology
• Pediatric
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:

• Historical Year - 2022
• Base Year - 2023
• Forecast Period - 2024 to 2032

Key Takeaways:

• Comprehensive market estimates and forecasts for the 2022-2032 period.
• Detailed regional analysis, including country-level insights.
• In-depth segmentation analysis, covering product types, applications, and end users.
• Competitive landscape profiling major market players and their strategic initiatives.
• Recommendations and actionable insights for stakeholders in the implantable infusion pumps market.

Table of Contents

Chapter 1. Global Implantable Infusion Pumps Market Executive Summary

• 1.1. Global Implantable Infusion Pumps Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product Type
  • 1.3.2. By Application
  • 1.3.3. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Implantable Infusion Pumps Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Implantable Infusion Pumps Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing Prevalence of Chronic Diseases
  • 3.1.2. Advancements in Drug Delivery Technologies
  • 3.1.3. Government Initiatives and Healthcare Infrastructure Enhancements
• 3.2. Market Challenges
  • 3.2.1. High Cost of Implantable Infusion Systems
  • 3.2.2. Need for Skilled Professionals
• 3.3. Market Opportunities
  • 3.3.1. Integration of Wireless Monitoring and Programmable Features
  • 3.3.2. Personalized Medicine and Targeted Therapies
  • 3.3.3. Expansion into Emerging Markets

Chapter 4. Global Implantable Infusion Pumps Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunities
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Implantable Infusion Pumps Market Size & Forecasts by Product Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Implantable Infusion Pumps Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 5.2.1. Piston Type Infusion Pumps
  • 5.2.2. Creeping Type Infusion Pumps
  • 5.2.3. Enteral Pump
  • 5.2.4. Elastomeric Pump
  • 5.2.5. Insulin Pump
  • 5.2.6. Syringe Pump

Chapter 6. Global Implantable Infusion Pumps Market Size & Forecasts by Application 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Implantable Infusion Pumps Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 6.2.1. Cancer Treatment
  • 6.2.2. Spasticity
  • 6.2.3. Analgesia
  • 6.2.4. Diabetes Mellitus
  • 6.2.5. Gastroenterology
  • 6.2.6. Hematology
  • 6.2.7. Pediatric
  • 6.2.8. Others

Chapter 7. Global Implantable Infusion Pumps Market Size & Forecasts by Region 2022-2032

• 7.1. North America Implantable Infusion Pumps Market
  • 7.1.1. U.S. Implantable Infusion Pumps Market
    • 7.1.1.1. Product Type Breakdown Size & Forecasts, 2022-2032
    • 7.1.1.2. Application Breakdown Size & Forecasts, 2022-2032
  • 7.1.2. Canada Implantable Infusion Pumps Market
• 7.2. Europe Implantable Infusion Pumps Market
  • 7.2.1. UK Implantable Infusion Pumps Market
  • 7.2.2. Germany Implantable Infusion Pumps Market
  • 7.2.3. France Implantable Infusion Pumps Market
  • 7.2.4. Spain Implantable Infusion Pumps Market
  • 7.2.5. Italy Implantable Infusion Pumps Market
  • 7.2.6. Rest of Europe Implantable Infusion Pumps Market
• 7.3. Asia-Pacific Implantable Infusion Pumps Market
  • 7.3.1. China Implantable Infusion Pumps Market
  • 7.3.2. India Implantable Infusion Pumps Market
  • 7.3.3. Japan Implantable Infusion Pumps Market
  • 7.3.4. Australia Implantable Infusion Pumps Market
  • 7.3.5. South Korea Implantable Infusion Pumps Market
  • 7.3.6. Rest of Asia-Pacific Implantable Infusion Pumps Market
• 7.4. Latin America Implantable Infusion Pumps Market
  • 7.4.1. Brazil Implantable Infusion Pumps Market
  • 7.4.2. Mexico Implantable Infusion Pumps Market
  • 7.4.3. Rest of Latin America Implantable Infusion Pumps Market
• 7.5. Middle East & Africa Implantable Infusion Pumps Market
  • 7.5.1. Saudi Arabia Implantable Infusion Pumps Market
  • 7.5.2. South Africa Implantable Infusion Pumps Market
  • 7.5.3. Rest of Middle East & Africa Implantable Infusion Pumps Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Medtronic PLC
  • 8.1.2. Smiths Medical
  • 8.1.3. Flowonix Medical Inc.
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Medtronic PLC
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. BD (Becton, Dickinson and Company)
  • 8.3.3. Baxter International Inc.
  • 8.3.4. Roche Diagnostics
  • 8.3.5. Fresenius Kabi AG
  • 8.3.6. Terumo Corporation
  • 8.3.7. ICU Medical Inc.
  • 8.3.8. Insulet Corporation
  • 8.3.9. Johnson & Johnson
  • 8.3.10. Moog Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes